Arch Therapeutics, Inc.

Ownership Transactions Reported by 7 Insiders

Symbol
ARTHQ, ARTH on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
235 Walnut Street, Suite 6, Framingham, MA

There are no Buy or Sell transactions made by insiders since 12/7/2024

Arch Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Abrams Chief Financial Officer $2.83K Aug 31, 2023
Laurence Hicks Director $2.83K Aug 31, 2023
Terrence Norchi PRESIDENT AND CHIEF EXECUTIVE, Director $1.89K Aug 31, 2023
Punit Dhillon Director Nov 10, 2022
Guy L. Fish Director Nov 10, 2022
Dan Yrigoyen Vice President, Sales Nov 10, 2022
James R. Sulat Director Sep 27, 2021

Recent Insider Transactions by Companies or Individuals for Arch Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.